Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6248894 | 1.00 | PTGS2 (0.81) | PTGS2PTGS1 | |
| SCHEMBL7779775 | 0.95 | PTGS2 (0.72) | PTGS2PTGS1 | |
| SCHEMBL7772815 | 0.92 | PTGS2 (0.68) | PTGS2PTGS1 | |
| SCHEMBL7780649 | 0.92 | PTGS2 (0.68) | PTGS2PTGS1 | |
| SCHEMBL7780015 | 0.91 | PTGS2 (0.67) | PTGS2PTGS1 | |
| SCHEMBL7780681 | 0.91 | PTGS2 (0.67) | PTGS2PTGS1 | |
| SCHEMBL7773167 | 0.90 | PTGS2 (1.00) | PTGS2PTGS1 | |
| SCHEMBL214172 | 0.90 | PTGS2 (1.00) | PTGS2PTGS1 | |
| SCHEMBL7778126 | 0.89 | PTGS2 (0.73) | PTGS2PTGS1 | |
| SCHEMBL7780369 | 0.89 | PTGS2 (0.65) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0772597-B1 | 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-1127878-A1 | 3,4 - substituted pyrazoles for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2001-08-29 | — | — | EP | disclosed |
| US-6028072-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 2000-02-22 | — | — | US | disclosed |
| EP-0772597-A1 | 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-05-14 | — | — | EP | disclosed |
| WO-1996003385-A1 | 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-02-08 | — | — | WO | disclosed |